almost significantp = 0.07
Interestingly, the treatment with Adrb2/Adrb3 agonists caused a significant shortening of the AHP half-decay time in WT MNs, and an almost significant shortening (p = 0.07) in SOD1 MNs ( Fig. 4K ).
Interestingly, the treatment with Adrb2/Adrb3 agonists caused a significant shortening of the AHP half-decay time in WT MNs, and an almost significant shortening (p = 0.07) in SOD1 MNs ( Fig. 4K ).
1D - E ) and Adrb3 was unaltered in Mmp9 + and showed a trend toward downregulation in Mmp9− MNs ( Fig. 1F - G ; all statistics are reported in Supplemental Excel Table 1 ).